---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-098074"
form_type: "8-K"
ticker: "SEER"
cik: "0001726445"
company_name: "Seer, Inc."
filed_at: "2024-08-16T23:59:59+00:00"
generated_at: "2026-05-31T08:51:47.219972+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Seer appoints Nicolas Roelofs to board as Lead Independent Director effective Aug 13, 2024

## Summary
- Roelofs replaces David Hallal as Lead Independent Director and joins CG&N and Science & Technology committees.
- Initial equity award of 69,470 stock options and 46,886 RSUs, vesting in three equal annual installments.
- Roelofs brings 35+ years experience including president of Agilent Life Sciences Group.
- No arrangement or understanding with any person regarding his election as director.

## SEC filing metadata
- accession: 0000950170-24-098074
- form_type: 8-K
- ticker: SEER
- cik: 0001726445
- company_name: Seer, Inc.
- filed_at: 2024-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726445/000095017024098074/0000950170-24-098074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726445/000095017024098074/ck0001726445-20240813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-098074
- JSON: https://secwatch.observer/filing/0000950170-24-098074.json
- Plain text: https://secwatch.observer/filing/0000950170-24-098074.txt

## Key facts
- Executive change
  Nicolas Henry Roelofs was appointed as Lead Independent Director at Seer, Inc..
  - Action: appointed
  - Role: Lead Independent Director
  source text: On August 13, 2024, the board of directors (the “Board”) of Seer, Inc. (the “Company”) appointed Nicolas Henry Roelofs, Ph.D. to the Board with a term expiring at the Company’s 2025 annual meeting of the stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726445/000095017024098074/0000950170-24-098074-index.htm
- Executive change
  David Hallal changed role as Lead Independent Director at Seer, Inc..
  - Action: replaced
  - Role: Lead Independent Director
  source text: The Company also announced that Dr. Roelofs would replace David Hallal as the Company’s Lead Independent Director and would serve on the Company’s Corporate Governance and Nominating Committee and Science and Technology Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726445/000095017024098074/0000950170-24-098074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.